Medacta Group SA (OTCMKTS:MEDGF – Get Free Report) fell 3.3% on Thursday. The stock traded as low as $145.08 and last traded at $145.08. Approximately 100 shares were traded during mid-day trading, an increase of 0% from the average daily volume of 100 shares. The stock had previously closed at $150.0640.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft started coverage on Medacta Group in a research note on Tuesday, September 15th. They issued a “hold” rating on the stock. One equities research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Medacta Group has an average rating of “Hold”.
Check Out Our Latest Report on Medacta Group
Medacta Group Price Performance
The business has a fifty day moving average of $142.26 and a 200-day moving average of $108.01.
Medacta Group Company Profile
Medacta Group is a Switzerland-based medical technology company focused on orthopedic care. Founded in 1999, the company develops and manufactures products and surgical techniques used in joint replacement and spine surgery.
Its portfolio includes implants and instruments for hip and knee replacement, as well as products for spine surgery and sports medicine. Medacta also provides surgical planning technologies and patient-specific solutions intended to support individualized procedures.
The company serves hospitals and surgeons internationally.
See Also
- Five stocks we like better than Medacta Group
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Medacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
